Literature DB >> 11526443

Retinoic acid receptor-independent mechanism of apoptosis of melanoma cells by the retinoid CD437 (AHPN).

X Zhao1, K Demary, L Wong, C Vaziri, A B McKenzie, T J Eberlein, R A Spanjaard.   

Abstract

Retinoic acid (RA) induces differentiation of S91 melanoma cells through activation of RA receptor (RAR)gamma without affecting cell viability. The novel RARgamma-agonist CD437 (AHPN), however, also induces concomitant apoptosis through an unknown mechanism which was investigated here. By utilizing DNA microarray analysis, five apoptosis-associated, CD437-induced transcripts (CITs) were identified. Interestingly, all CITs are also regulated by p53 in a DNA damage response, and consistent with this interpretation, CD437 was found to cause DNA adduct-formation. However, p53 is not required for CD437-dependent regulation of CITs. Among this set of genes, induction of p21(WAF1/CIP1) is likely to be responsible for early S-phase growth-arrest of CD437-treated cells, whereas ei24 is a critical mediator of CD437-induced apoptosis in S91 cells. These data suggest an RAR-independent mechanism in which CD437 causes DNA adduct-formation, resulting in induction of a p53-independent DNA damage response, and subsequent growth-arrest and apoptosis. CD437-mediated DNA adduct-formation may also explain its apoptotic effects in other cell types.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11526443     DOI: 10.1038/sj.cdd.4400894

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  9 in total

Review 1.  The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives.

Authors:  Lukas Wanka; Khalid Iqbal; Peter R Schreiner
Journal:  Chem Rev       Date:  2013-02-25       Impact factor: 60.622

2.  Adamantyl-substituted retinoid-related molecules bind small heterodimer partner and modulate the Sin3A repressor.

Authors:  Lulu Farhana; Marcia I Dawson; Mark Leid; Li Wang; David D Moore; Gang Liu; Zeben Xia; Joseph A Fontana
Journal:  Cancer Res       Date:  2007-01-01       Impact factor: 12.701

3.  Colitis and colitis-associated cancer are exacerbated in mice deficient for tumor protein 53-induced nuclear protein 1.

Authors:  Julien Gommeaux; Carla Cano; Stéphane Garcia; Meritxell Gironella; Sylvia Pietri; Marcel Culcasi; Marie-Josèphe Pébusque; Bernard Malissen; Nelson Dusetti; Juan Iovanna; Alice Carrier
Journal:  Mol Cell Biol       Date:  2007-01-22       Impact factor: 4.272

4.  Oncogenic activity of retinoic acid receptor γ is exhibited through activation of the Akt/NF-κB and Wnt/β-catenin pathways in cholangiocarcinoma.

Authors:  Gui-Li Huang; Qi Luo; Gang Rui; Wei Zhang; Qiu-Yan Zhang; Qing-Xi Chen; Dong-Yan Shen
Journal:  Mol Cell Biol       Date:  2013-06-24       Impact factor: 4.272

5.  Development of resistance to the atypical retinoid, ST1926, in the lung carcinoma cell line H460 is associated with reduced formation of DNA strand breaks and a defective DNA damage response.

Authors:  Valentina Zuco; Chiara Zanchi; Cinzia Lanzi; Giovanni L Beretta; Rosanna Supino; Claudio Pisano; Marcella Barbarino; Romina Zanier; Federica Bucci; Concetta Aulicino; Paolo Carminati; Franco Zunino
Journal:  Neoplasia       Date:  2005-07       Impact factor: 5.715

6.  Loss of putative tumor suppressor EI24/PIG8 confers resistance to etoposide.

Authors:  Christina N Mork; Douglas V Faller; Remco A Spanjaard
Journal:  FEBS Lett       Date:  2007-11-05       Impact factor: 4.124

7.  Etoposide-induced protein 2.4 functions as a regulator of the calcium ATPase and protects pancreatic β-cell survival.

Authors:  Lin Yuan; Huiyu Wang; Qi Liu; Zhe Wang; Mingshu Zhang; Yan Zhao; Kuo Liang; Liangyi Chen; Tao Xu; Pingyong Xu
Journal:  J Biol Chem       Date:  2018-05-16       Impact factor: 5.157

8.  Selective killing of cancer cells by beta -lapachone: direct checkpoint activation as a strategy against cancer.

Authors:  Youzhi Li; Xiangao Sun; J Thomas LaMont; Arthur B Pardee; Chiang J Li
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-21       Impact factor: 12.779

9.  Effect of Combination Therapy of Methotrexate with Vitamin A in Patients with Low Risk GTN (Gestational Trophoblastic Neoplasia).

Authors:  Sedigheh Ghasemian; Zohreh Yousefi; Marjaneh Farazestanian; Leila Mousavi Seresht; Mohsen Foroughipour; Saeid Akhlaghi
Journal:  Iran J Pharm Res       Date:  2018       Impact factor: 1.696

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.